Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-03 5:25 pm Purchase | 2025-06-27 | 13G | Bone Biologics Corporation BBLG | Mitchell P. Kopin | 153,219 9.990% | 153,219 (New Position) | Filing History |
| 2025-07-03 5:24 pm Purchase | 2025-06-27 | 13G | Ascent Solar Technologies, Inc. Common Stock ASTI | Mitchell P. Kopin | 317,830 9.990% | 317,830 (New Position) | Filing History |
| 2025-07-01 4:44 pm Purchase | 2025-06-25 | 13G | ReWalk Robotics Ltd. LFWD | Mitchell P. Kopin | 819,443 4.990% | 265,622 (+47.96%) | Filing History |
| 2025-06-27 5:08 pm Purchase | 2025-06-20 | 13G | SeaStar Medical Holding Corporation ICU | Mitchell P. Kopin | 1,803,026 9.990% | 1,803,026 (New Position) | Filing History |
| 2025-06-25 4:38 pm Unchanged | 2025-06-18 | 13G | Aptevo Therapeutics Inc. APVO | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-06-23 06:03 am Purchase | 2025-06-17 | 13G | Processa Pharmaceuticals, Inc. PCSA | Mitchell P. Kopin | 3,018,238 9.990% | 3,018,238 (New Position) | Filing History |
| 2025-06-23 06:03 am Purchase | 2025-06-17 | 13G | Adial Pharmaceuticals, Inc. ADIL | Mitchell P. Kopin | 446,282 2.800% | 446,282 (New Position) | Filing History |
| 2025-06-13 5:31 pm Purchase | 2025-06-06 | 13G | Venus Concept Inc. VERO | Mitchell P. Kopin | 120,474 4.990% | 82,698 (+218.92%) | Filing History |
| 2025-06-13 5:31 pm Purchase | 2025-06-09 | 13G | Nuwellis, Inc. NUWE | Mitchell P. Kopin | 251,087 4.990% | 251,087 (New Position) | Filing History |
| 2025-06-13 5:30 pm Purchase | 2025-06-11 | 13G | Draganfly Inc. DPRO | Mitchell P. Kopin | 670,154 4.990% | 670,154 (New Position) | Filing History |
| 2025-05-30 5:12 pm Purchase | 2025-05-28 | 13G | Imunon, Inc. IMNN | Mitchell P. Kopin | 1,111,112 5.500% | 1,111,112 (New Position) | Filing History |
| 2025-05-27 5:30 pm Purchase | 2025-05-20 | 13G | Jaguar Health, Inc. JAGX | Mitchell P. Kopin | 65,002 4.990% | 65,002 (New Position) | Filing History |
| 2025-05-23 4:18 pm Purchase | 2025-05-19 | 13G | Cemtrex, Inc. CETX | Mitchell P. Kopin | 198,066 9.990% | 198,066 (New Position) | Filing History |
| 2025-05-23 4:17 pm Purchase | 2025-05-19 | 13G | Sunshine Biopharma, Inc. SBFM | Mitchell P. Kopin | 505,653 9.990% | 505,653 (New Position) | Filing History |
| 2025-05-21 5:19 pm Purchase | 2025-05-15 | 13G | Silo Pharma, Inc. SILO | Mitchell P. Kopin | 784,630 9.990% | 549,103 (+233.14%) | Filing History |
| 2025-05-12 4:08 pm Purchase | 2025-05-06 | 13G | Pasithea Therapeutics Corp. KTTA | Mitchell P. Kopin | 317,863 4.990% | 317,863 (New Position) | Filing History |
| 2025-05-09 4:04 pm Purchase | 2025-03-31 | 13G | NAYA Biosciences, Inc. Common Stock IVF | Mitchell P. Kopin | 34,981 4.990% | 34,981 (New Position) | Filing History |
| 2025-05-09 4:04 pm Sale | 2025-03-31 | 13G | Dermata Therapeutics, Inc. DRMA | Mitchell P. Kopin | 23,340 0.400% | -239,128 (-91.11%) | Filing History |
| 2025-05-09 4:03 pm Purchase | 2025-03-31 | 13G | Mustang Bio, Inc. MBIO | Mitchell P. Kopin | 236,452 8.800% | 49,900 (+26.75%) | Filing History |
| 2025-05-09 4:02 pm Purchase | 2025-03-31 | 13G | Color Star Technology Co., Ltd. ADD | Mitchell P. Kopin | 2,668,704 9.990% | 2,164,216 (+428.99%) | Filing History |